Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Molecular Pharmacology
  4. Volume 17, Issue 1
  5. Article
Volume 17, Issue 1
  • ISSN: 1874-4672
  • E-ISSN: 1874-4702
file format text download EPUB
file format pdf download PDF
side by side viewer icon HTML

Abstract

Background

Liver fibrosis is associated with the activation of hepatic stellate cells (HSCs). Inhibition of HSCs activation is a strategy for alleviating hepatic fibrogenesis. CD73 is involved in liver disease development, while the mechanism remains unclear.

Objective

This study aimed to investigate the effect of CD73 targeting inhibition on liver fibrosis.

Methods

Intraperitoneal injection of CCl was used to induce liver fibrosis in mice models. Adenosine 5′-(α, β-methylene) diphosphate sodium salt (APCP) was used for CD73 blockade. The siRNA was used to induce CD73 knockdown in HSCs. LX2 and HSC-T6 were used to investigate the role of CD73 in HSCs activation .

Results

The results showed that APCP treatment could alleviate hepatic fibrosis. In fibrotic liver tissues, CD73 exhibited a positive correlation with markers of HSCs activation. Furthermore, APCP treatment and CD73 knockdown could inhibit HSCs (LX2 and HSC-T6) activation and proliferation. By using RNA sequencing of liver tissues from control, CCl-mice, and APCP-treated mice, 851 genes that were significantly changed in CCl mice (. control) were reversed by APCP treatment. These genes were mainly enriched in cell division-associated biological processes. Moreover, we found that CD73 might be associated with autophagy in HSCs. In fibrotic liver tissues and HSCs, ATG5 and Beclin1 expression could be downregulated by CD73 knockdown and APCP treatment.

Conclusion

This study demonstrated the effects and mechanism of CD73 in HSCs activation and proliferation, which presents the therapeutical potential of CD73 blockage for liver fibrosis.

© 2024 Bentham Science Publishers
© 2024 The Author(s). Published by Bentham Science Publisher. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cmp/10.2174/1874467216666230322113039
2024-01-01
2024-11-23

  • From This Site

    /content/journals/cmp/10.2174/1874467216666230322113039
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cmp/17/1/CMP-17-E220323214863.html?itemId=/content/journals/cmp/10.2174/1874467216666230322113039&mimeType=html&fmt=ahah

References

  1. CaligiuriA. GentiliniA. PastoreM. GittoS. MarraF. Cellular and molecular mechanisms underlying liver fibrosis regression.Cells20211010275910.3390/cells1010275934685739
     [Google Scholar]
  2. KumarS. DuanQ. WuR. HarrisE.N. SuQ. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis.Adv. Drug Deliv. Rev.202117611386910.1016/j.addr.2021.11386934280515
     [Google Scholar]
  3. LiJ. DengX. WangS. JiangQ. XuK. Resolvin D1 attenuates CCl4 induced liver fibrosis by inhibiting autophagy-mediated HSC activation via AKT/mTOR pathway.Front. Pharmacol.20211279241410.3389/fphar.2021.79241434987404
     [Google Scholar]
  4. MazzaG. Al-AkkadW. RomboutsK. Engineering in vitro models of hepatofibrogenesis.Adv. Drug Deliv. Rev.201712114715710.1016/j.addr.2017.05.01828578016
     [Google Scholar]
  5. LuoN. LiJ. WeiY. LuJ. DongR. Hepatic stellate cell: A double-edged sword in the liver.Physiol. Res.202170682182910.33549/physiolres.93475534717063
     [Google Scholar]
  6. CaiX. WangJ. WangJ. ZhouQ. YangB. HeQ. WengQ. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy.Pharmacol. Res.202015510472010.1016/j.phrs.2020.10472032092405
     [Google Scholar]
  7. FogliaB. NovoE. ProtopapaF. MaggioraM. BoccaC. CannitoS. ParolaM. Hypoxia, hypoxia-inducible factors and liver fibrosis.Cells2021107176410.3390/cells1007176434359934
     [Google Scholar]
  8. JiaW. ZhouT. DaiJ. LiuZ. ZhangY. ZangD. LvX. CD73 regulates hepatic stellate cells activation and proliferation through Wnt/β-catenin signaling pathway.Eur. J. Pharmacol.202189017366710.1016/j.ejphar.2020.17366733121948
     [Google Scholar]
  9. MinorM. AlcedoK.P. BattagliaR.A. SniderN.T. Cell type- and tissue-specific functions of ecto-5′-nucleotidase (CD73).Am. J. Physiol. Cell Physiol.20193176C1079C109210.1152/ajpcell.00285.201931461341
     [Google Scholar]
  10. AlcedoK.P. BowserJ.L. SniderN.T. The elegant complexity of mammalian ecto-5′-nucleotidase (CD73).Trends Cell Biol.2021311082984210.1016/j.tcb.2021.05.00834116887
     [Google Scholar]
  11. NocentiniA. CapassoC. SupuranC.T. Small-molecule CD73 inhibitors for the immunotherapy of cancer: A patent and literature review.Expert Opin Ther Pat.2017867876
     [Google Scholar]
  12. ShuaiC. XiaG. YuanF. WangS. LvX. CD39-mediated ATP-adenosine signalling promotes hepatic stellate cell activation and alcoholic liver disease.Eur. J. Pharmacol.202190517419810.1016/j.ejphar.2021.17419834033815
     [Google Scholar]
  13. ShenM. LiY. WangY. ShaoJ. ZhangF. YinG. ChenA. ZhangZ. ZhengS. N6-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells.Redox Biol.20214710215110.1016/j.redox.2021.10215134607160
     [Google Scholar]
  14. LuoN. LiJ. ChenY. XuY. WeiY. LuJ. DongR. Hepatic stellate cell reprogramming via exosome-mediated CRISPR/dCas9-VP64 delivery.Drug Deliv.2021281101810.1080/10717544.2020.185091733336604
     [Google Scholar]
  15. TanZ. SunH. XueT. GanC. LiuH. XieY. YaoY. YeT. Liver fibrosis: Therapeutic targets and advances in drug therapy.Front. Cell Dev. Biol.2021973017610.3389/fcell.2021.73017634621747
     [Google Scholar]
  16. SunP. ZhengX. LiX. The effects of CD73 on gastrointestinal cancer progression and treatment.J. Oncol.202220221810.1155/2022/433032935620732
     [Google Scholar]
  17. YuX. LiuW. WangZ. WangH. LiuJ. HuangC. ZhaoT. WangX. GaoS. MaY. WuL. LiX. YangS. HaoJ. CD73 induces gemcitabine resistance in pancreatic ductal adenocarcinoma: A promising target with non-canonical mechanisms.Cancer Lett.202151928930310.1016/j.canlet.2021.07.02434302921
     [Google Scholar]
  18. WirsdörferF. de LeveS. CappucciniF. EldhT. MeyerA.V. GauE. ThompsonL.F. ChenN.Y. Karmouty-QuintanaH. FischerU. KasperM. KleinD. RitcheyJ.W. BlackburnM.R. WestendorfA.M. StuschkeM. JendrossekV. Extracellular adenosine production by ecto-5′-nucleotidase (CD73) enhances radiation-induced lung fibrosis.Cancer Res.201676103045305610.1158/0008‑5472.CAN‑15‑231026921334
     [Google Scholar]
  19. PerryH.M. GörldtN. SungS.J. HuangL. RudnickaK.P. EncarnacionI.M. BajwaA. TanakaS. PoudelN. YaoJ. RosinD.L. SchraderJ. OkusaM.D. Perivascular CD73 + cells attenuate inflammation and interstitial fibrosis in the kidney microenvironment.Am. J. Physiol. Renal Physiol.20193173F658F66910.1152/ajprenal.00243.201931364375
     [Google Scholar]
  20. FernándezP. Perez-AsoM. SmithG. WilderT. TrzaskaS. ChiribogaL. FranksA.Jr RobsonS.C. CronsteinB.N. ChanE.S.L. Extracellular generation of adenosine by the ectonucleotidases CD39 and CD73 promotes dermal fibrosis.Am. J. Pathol.201318361740174610.1016/j.ajpath.2013.08.02424266925
     [Google Scholar]
  21. de LeveS. WirsdörferF. JendrossekV. The CD73/Ado system—A new player in rt induced adverse late effects.Cancers20191110157810.3390/cancers1110157831623231
     [Google Scholar]
  22. PengZ. FernandezP. WilderT. YeeH. ChiribogaL. ChanE.S.L. CronsteinB.N. Ecto-5′-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis.Nucleosides Nucleotides Nucleic Acids2008276-782182410.1080/1525777080214640318600546
     [Google Scholar]
  23. LiuZ. WuX. WangQ. LiZ. LiuX. ShengX. ZhuH. ZhangM. XuJ. FengX. WuB. LvX. CD73-Adenosine A1R axis regulates the activation and apoptosis of hepatic stellate cells through the PLC-IP3-Ca2+/DAG-PKC signaling pathway.Front. Pharmacol.20221392288510.3389/fphar.2022.92288535784730
     [Google Scholar]
  24. KitadaM. KoyaD. Autophagy in metabolic disease and ageing.Nat. Rev. Endocrinol.2021171164766110.1038/s41574‑021‑00551‑934508250
     [Google Scholar]
  25. WangB. YangH. FanY. YangY. CaoW. JiaY. CaoY. SunK. PangZ. DuH. 3-Methyladenine ameliorates liver fibrosis through autophagy regulated by the NF-κB signaling pathways on hepatic stellate cell.Oncotarget201786410760310761110.18632/oncotarget.2253929296191
     [Google Scholar]
  26. ZhaoJ. PengL. CuiR. GuoX. YanM. Dimethyl α-ketoglutarate reduces CCl4-induced liver fibrosis through inhibition of autophagy in hepatic stellate cells.Biochem. Biophys. Res. Commun.20164811-2909610.1016/j.bbrc.2016.11.01027823933
     [Google Scholar]
  27. YangR. HuZ. ZhangP. WuS. SongZ. ShenX. WeiZ. Probucol ameliorates hepatic stellate cell activation and autophagy is associated with farnesoid X receptor.J. Pharmacol. Sci.2019139212012810.1016/j.jphs.2018.12.00530638990
     [Google Scholar]
  28. QiaoZ. LiX. KangN. YangY. ChenC. WuT. ZhaoM. LiuY. JiX. A novel specific anti-CD73 antibody inhibits triple-negative breast cancer cell motility by regulating autophagy.Int. J. Mol. Sci.2019205105710.3390/ijms2005105730823477
     [Google Scholar]
  29. ShiQ. WangQ. ChenJ. XiaF. QiuC. LiM. ZhaoM. ZhangQ. LuoP. LuT. ZhangY. XuL. HeX. ZhongT. LinN. GuoQ. Transcriptome and lipid metabolomics-based discovery: Glycyrrhizic acid alleviates Tripterygium glycoside tablet-induced acute liver injury by regulating the activities of CYP and the metabolism of phosphoglycerides.Front. Pharmacol.20221282215410.3389/fphar.2021.82215435237151
     [Google Scholar]
  30. JiangY. ZhouY. SongS. FanS. GaoY. LiY. HuangM. BiH. St. john’s wort exacerbates acetaminophen-induced liver injury by activation of PXR and CYP-mediated bioactivation.Toxicol. Sci.20221901546310.1093/toxsci/kfac09436073954
     [Google Scholar]
/content/journals/cmp/10.2174/1874467216666230322113039
Loading
CD73 Blockade Alleviated Hepatic Fibrosis via Inhibiting Hepatic Stellate Cells Proliferation and Activation
Curr Mol Pharmacol 17, E220323214863 (2024); https://doi.org/10.2174/1874467216666230322113039
/content/journals/cmp/10.2174/1874467216666230322113039
/content/journals/cmp/10.2174/1874467216666230322113039
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): APCP treatment; Autophagy; CD73; Fibrotic liver tissues; HSC activation; Liver fibrosis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test